Strides Pharma receives USFDA approval for Triamcinolone Acetonide Ointment USP, 0.05%
Jun 03, 2020, at 08:26 pm
Bengaluru/IBNS: Strides Pharma Science Limited (Strides) announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Triamcinolone Acetonide Ointment USP, 0.05% from the United States Food & Drug Administration (USFDA).
Strides annonces that it commenced export of Favipiravir Antiviral Tablets developed by it
May 01, 2020, at 02:55 pm
Kolkata/IBNS: Strides Pharma Science Limited (Strides), a global pharmaceutical company, has announced that it has developed and commercialized Favipiravir Antiviral tablets.
Bengaluru-based Strides Consumer forays into eastern India with two new products
Feb 05, 2020, at 04:29 pm
Kolkata/IBNS: Bengaluru-based consumer health care company, Strides Consumer Private Limited (SCPL), recently entered the market in eastern India with two new products.
Dr. R Ananthanarayanan takes over as CEO and MD of Strides Pharma from founder Arun Kumar
Jan 09, 2020, at 03:52 pm
Kolkata/IBNS: Strides Pharma Science Limited (Strides) announced the appointment of Dr. R Ananthanarayanan as Chief Executive Officer (CEO) and Managing Director (MD) of of the company, effective January 9, 2020.